This medical animation demonstrates the mechanism of action (MOA) of Evenity (romosozumab), a novel bone forming agent that inhibits the protein sclerostin to promote gains in bone mass. We created an isolated bone cube and visually distinct cell groups to clearly illustrate the complementary processes of bone formation and bone resorption in osteoporosis and its treatment. By top medical animation company, AXS Studio.
Keywords: Animation, 3D, Advertising / Marketing, Professional Education, Biotechnology, Cell biology / Histology, Orthopaedics, Pharmacology, Mechanism of Action (MOA)
AXS Studio